Extended Model Predicts Glycaemic Response to Oral and Injectable Semaglutide Read more about Extended Model Predicts Glycaemic Response to Oral and Injectable Semaglutide
Oral Semaglutide Reduces Hospitalisations in High-Risk Type 2 Diabetes Read more about Oral Semaglutide Reduces Hospitalisations in High-Risk Type 2 Diabetes
GLP1-RA Plus SGLT2i Combination Offers Extra Kidney Protection in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about GLP1-RA Plus SGLT2i Combination Offers Extra Kidney Protection in Type 2 Diabetes
HTD1801 Significantly Improves Blood Sugar and Cardiometabolic Health in Type 2 Diabetes Read more about HTD1801 Significantly Improves Blood Sugar and Cardiometabolic Health in Type 2 Diabetes
Cortisol-Targeted Therapy Improves Glycemic Control and Weight in Difficult-to-Treat Type 2 Diabetes Read more about Cortisol-Targeted Therapy Improves Glycemic Control and Weight in Difficult-to-Treat Type 2 Diabetes
Tirzepatide Drives Significant Weight Loss and Insulin Reduction in Type 1 Diabetes Read more about Tirzepatide Drives Significant Weight Loss and Insulin Reduction in Type 1 Diabetes
Semaglutide and Cagrilintide Combination Achieves Dramatic Weight Loss in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about Semaglutide and Cagrilintide Combination Achieves Dramatic Weight Loss in Type 2 Diabetes
Automated Insulin Delivery Improves Glycemic Control in Adults with T1D Tags Others Delivery devices Read more about Automated Insulin Delivery Improves Glycemic Control in Adults with T1D
Automated Insulin Delivery Sustains Glycemic Control and Reduces Patient Burden Over 3 Years Tags Others Delivery devices Read more about Automated Insulin Delivery Sustains Glycemic Control and Reduces Patient Burden Over 3 Years
Fully Human Anti-Thymocyte Antibody Shows Favorable Safety in Early T1D Trial Read more about Fully Human Anti-Thymocyte Antibody Shows Favorable Safety in Early T1D Trial